285 related articles for article (PubMed ID: 32361797)
1. CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
Tsai PC; Yeh YC; Hsu PK; Chen CK; Chou TY; Wu YC
Ann Surg Oncol; 2020 Oct; 27(11):4405-4412. PubMed ID: 32361797
[TBL] [Abstract][Full Text] [Related]
2. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
3. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography density is not associated with pathological tumor invasion for pure ground-glass nodules.
Fu F; Zhang Y; Wang S; Li Y; Wang Z; Hu H; Chen H
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):451-459.e3. PubMed ID: 32711984
[TBL] [Abstract][Full Text] [Related]
5. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
6. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
7. Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens.
Huang KY; Ko PZ; Yao CW; Hsu CN; Fang HY; Tu CY; Chen HJ
J Thorac Cardiovasc Surg; 2017 Jul; 154(1):332-339.e1. PubMed ID: 28366548
[TBL] [Abstract][Full Text] [Related]
8. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
9. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
13. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
14. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
15. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
16. Three-Dimensional Ground Glass Opacity Ratio in CT Images Can Predict Tumor Invasiveness of Stage IA Lung Cancer.
Yu WS; Hong SR; Lee JG; Lee JS; Jung HS; Kim DJ; Chung KY; Lee CY
Yonsei Med J; 2016 Sep; 57(5):1131-8. PubMed ID: 27401643
[TBL] [Abstract][Full Text] [Related]
17. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
[TBL] [Abstract][Full Text] [Related]
18. Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma.
Kim TH; Buonocore D; Petre EN; Durack JC; Maybody M; Johnston RP; Travis WD; Adusumilli PS; Solomon SB; Ziv E
Ann Thorac Surg; 2019 Aug; 108(2):392-398. PubMed ID: 30986416
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.
Matsuzawa R; Kirita K; Kuwata T; Umemura S; Matsumoto S; Fujii S; Yoh K; Kojima M; Niho S; Ohmatsu H; Ochiai A; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Apr; 94():1-6. PubMed ID: 26973199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
